5 Best Performing Biotech Stocks in 2022

2. Belite Bio, Inc (NASDAQ:BLTE)

Number of Hedge Fund Holders: N/A

YTD Share Price Gain as of December 28: 180.93%

Belite Bio, Inc (NASDAQ:BLTE) is a California-based clinical-stage biopharmaceutical drug development company, engaged in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. On November 18, Belite Bio, Inc (NASDAQ:BLTE) announced that, following discussions with the FDA, it has finalized the study design for its planned Phase 3 clinical trial to evaluate the efficacy and safety of Tinlarebant in patients with geographic atrophy associated with Dry AMD.

Belite Bio, Inc (NASDAQ:BLTE) shares have gained nearly 181% year-to-date as of December 28, making it one of the best performing biotech stocks this year.